{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:21:39Z","timestamp":1789849299624,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1520-4","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T19:47:34Z","timestamp":1461959254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Potential impact of multiple interventions on HIV incidence in a hyperendemic region in Western Kenya: a modelling study"],"prefix":"10.1186","volume":"16","author":[{"given":"St\u00e9phanie","family":"Blaizot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Riche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Kirubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Ecochard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Etard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"key":"1520_CR1","volume-title":"Global report: UNAIDS report on the global AIDS epidemic","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2013","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV\/AIDS (UNAIDS); 2013."},{"issue":"12","key":"1520_CR2","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1097\/QAD.0b013e328353b7b9","volume":"26","author":"JW Gargano","year":"2012","unstructured":"Gargano JW, Laserson K, Muttai H, Odhiambo F, Orimba V, Adamu-Zeh M, et al. The adult population impact of HIV care and antiretroviral therapy in a resource poor setting, 2003\u20132008. AIDS. 2012;26(12):1545\u201354.","journal-title":"AIDS"},{"issue":"6122","key":"1520_CR3","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1126\/science.1230413","volume":"339","author":"J Bor","year":"2013","unstructured":"Bor J, Herbst AJ, Newell ML, Barnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science. 2013;339(6122):961\u20135.","journal-title":"Science"},{"issue":"8","key":"1520_CR4","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1111\/j.1365-3156.2012.02929.x","volume":"17","author":"M Chihana","year":"2012","unstructured":"Chihana M, Floyd S, Molesworth A, Crampin AC, Kayuni N, Price A, et al. Adult mortality and probable cause of death in rural northern Malawi in the era of HIV treatment. Trop Med Int Health. 2012;17(8):e74\u201383.","journal-title":"Trop Med Int Health"},{"issue":"18","key":"1520_CR5","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","volume":"331","author":"EM Connor","year":"1994","unstructured":"Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O\u2019Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331(18):1173\u201380.","journal-title":"N Engl J Med"},{"issue":"6","key":"1520_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1056\/NEJM199908053410602","volume":"341","author":"PM Garcia","year":"1999","unstructured":"Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med. 1999;341(6):394\u2013402.","journal-title":"N Engl J Med"},{"issue":"13","key":"1520_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJM200003303421303","volume":"342","author":"TC Quinn","year":"2000","unstructured":"Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342(13):921\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"1520_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/01.qai.0000157389.78374.45","volume":"40","author":"J Castilla","year":"2005","unstructured":"Castilla J, Del Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr. 2005;40(1):96\u2013101.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"1520_CR9","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1097\/QAD.0b013e32832b7dca","volume":"23","author":"S Attia","year":"2009","unstructured":"Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23(11):1397\u2013404.","journal-title":"AIDS"},{"issue":"11","key":"1520_CR10","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1371\/journal.pmed.0020298","volume":"2","author":"B Auvert","year":"2005","unstructured":"Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(11):e298.","journal-title":"PLoS Med"},{"issue":"9562","key":"1520_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0140-6736(07)60312-2","volume":"369","author":"RC Bailey","year":"2007","unstructured":"Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643\u201356.","journal-title":"Lancet"},{"issue":"9562","key":"1520_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(07)60313-4","volume":"369","author":"RH Gray","year":"2007","unstructured":"Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657\u201366.","journal-title":"Lancet"},{"issue":"9","key":"1520_CR13","doi-asserted-by":"publisher","first-page":"e1001509","DOI":"10.1371\/journal.pmed.1001509","volume":"10","author":"B Auvert","year":"2013","unstructured":"Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, Bouscaillou J, et al. Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys. PLoS Med. 2013;10(9):e1001509.","journal-title":"PLoS Med"},{"key":"1520_CR14","unstructured":"Microbicide Trials Network (MTN). http:\/\/www.mtnstopshiv.org\/node\/2003 . Accessed March 2014."},{"issue":"5996","key":"1520_CR15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.1193748","volume":"329","author":"Q Abdool Karim","year":"2010","unstructured":"Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168\u201374.","journal-title":"Science"},{"issue":"5","key":"1520_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Damme Van","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411\u201322.","journal-title":"N Engl J Med"},{"issue":"5","key":"1520_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"issue":"5","key":"1520_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423\u201334.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"1520_CR19","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1097\/QAI.0b013e3182986f69","volume":"63","author":"JM Baeten","year":"2013","unstructured":"Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: where have we been and where are we going? J Acquir Immune Defic Syndr. 2013;63 Suppl 2:S122\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"1520_CR20","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/QAI.0000000000000124","volume":"66","author":"DO Kimanga","year":"2014","unstructured":"Kimanga DO, Ogola S, Umuro M, Ng\u2019ang\u2019a A, Kimondo L, Murithi P, et al. Prevalence and incidence of HIV infection, trends, and risk factors among persons aged 15\u201364 years in Kenya: results from a nationally representative study. J Acquir Immune Defic Syndr. 2014;66 Suppl 1:S13\u201326.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"1520_CR21","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1097\/QAD.0000000000000741","volume":"29","author":"D Maman","year":"2015","unstructured":"Maman D, Zeh C, Mukui I, Kirubi B, Masson S, Opolo V, et al. Cascade of HIV care and population viral suppression in a high-burden region of Kenya. AIDS. 2015;29(12):1557\u201365.","journal-title":"AIDS"},{"issue":"6","key":"1520_CR22","doi-asserted-by":"publisher","first-page":"e0130387","DOI":"10.1371\/journal.pone.0130387","volume":"10","author":"S Blaizot","year":"2015","unstructured":"Blaizot S, Riche B, Maman D, Mukui I, Kirubi B, Etard JF, et al. Estimation and short-term prediction of the course of the HIV epidemic using demographic and health survey methodology-like data. PLoS One. 2015;10(6):e0130387.","journal-title":"PLoS One"},{"key":"1520_CR23","unstructured":"Measure DHS, ICF International. Available at URL: http:\/\/dhsprogram.com . Accessed August 2014."},{"issue":"6","key":"1520_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493\u2013505.","journal-title":"N Engl J Med"},{"key":"1520_CR25","volume-title":"Consolidated guidelines on general HIV care and the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Consolidated guidelines on general HIV care and the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2013."},{"issue":"4","key":"1520_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2174\/1568005033480999","volume":"3","author":"S Blower","year":"2003","unstructured":"Blower S, Ma L, Farmer P, Koenig S. Predicting the impact of antiretrovirals in resource-poor settings: preventing HIV infections whilst controlling drug resistance. Curr Drug Targets Infect Disord. 2003;3(4):345\u201353.","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"2","key":"1520_CR27","first-page":"89","volume":"80","author":"NJ Nagelkerke","year":"2002","unstructured":"Nagelkerke NJ, Jha P, de Vlas SJ, Korenromp EL, Moses S, Blanchard JF, et al. Modelling HIV\/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission. Bull World Health Organ. 2002;80(2):89\u201396.","journal-title":"Bull World Health Organ"},{"issue":"7","key":"1520_CR28","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nm0702-651","volume":"8","author":"GP Garnett","year":"2002","unstructured":"Garnett GP, Bartley L, Grassly NC, Anderson RM. Antiretroviral therapy to treat and prevent HIV\/AIDS in resource-poor settings. Nat Med. 2002;8(7):651\u20134.","journal-title":"Nat Med"},{"key":"1520_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4054\/DemRes.2006.14.22","volume":"14","author":"LF Johnson","year":"2006","unstructured":"Johnson LF, Dorrington RE. Modelling the demographic impact of HIV\/AIDS in South Africa and the likely impact of interventions. Demogr Res. 2006;14:22.","journal-title":"Demogr Res"},{"issue":"38","key":"1520_CR30","doi-asserted-by":"publisher","first-page":"14228","DOI":"10.1073\/pnas.0509689103","volume":"103","author":"DP Wilson","year":"2006","unstructured":"Wilson DP, Kahn J, Blower SM. Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: the effect of the urban\u2013rural divide. Proc Natl Acad Sci U S A. 2006;103(38):14228\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1520_CR31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/QAI.0b013e3181342564","volume":"46","author":"A Vijayaraghavan","year":"2007","unstructured":"Vijayaraghavan A, Efrusy MB, Mazonson PD, Ebrahim O, Sanne IM, Santas CC. Cost-effectiveness of alternative strategies for initiating and monitoring highly active antiretroviral therapy in the developing world. J Acquir Immune Defic Syndr. 2007;46(1):91\u2013100.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9657","key":"1520_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","volume":"373","author":"RM Granich","year":"2009","unstructured":"Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48\u201357.","journal-title":"Lancet"},{"issue":"5","key":"1520_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/QAD.0b013e32833433fe","volume":"24","author":"PJ Dodd","year":"2010","unstructured":"Dodd PJ, Garnett GP, Hallett TB. Examining the promise of HIV elimination by \u2018test and treat\u2019 in hyperendemic settings. AIDS. 2010;24(5):729\u201335.","journal-title":"AIDS"},{"issue":"9907","key":"1520_CR34","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(13)62539-8","volume":"382","author":"PE Fast","year":"2013","unstructured":"Fast PE, Price MA, Rida WN, Kamali A, Karita E. WHO\u2019s new guidelines for antiretroviral treatment. Lancet. 2013;382(9907):1778\u20139.","journal-title":"Lancet"},{"key":"1520_CR35","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S2214-109X(13)70172-4","volume":"2","author":"JW Eaton","year":"2014","unstructured":"Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, et al. Health benefits, costs, and cost-eff ectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2014;2:e23\u201334.","journal-title":"Lancet Glob Health"},{"key":"1520_CR36","doi-asserted-by":"publisher","first-page":"b1649","DOI":"10.1136\/bmj.b1649","volume":"338","author":"E Wood","year":"2009","unstructured":"Wood E, Kerr T, Marshall BD, Li K, Zhang R, Hogg RS, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649.","journal-title":"BMJ"},{"issue":"6","key":"1520_CR37","doi-asserted-by":"publisher","first-page":"e11068","DOI":"10.1371\/journal.pone.0011068","volume":"5","author":"M Das","year":"2010","unstructured":"Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland W, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010;5(6):e11068.","journal-title":"PLoS One"},{"issue":"3","key":"1520_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/QAD.0b013e32834de5fe","volume":"26","author":"AD Castel","year":"2012","unstructured":"Castel AD, Befus M, Willis S, Griffin A, West T, Hader S, et al. Use of the community viral load as a population-based biomarker of HIV burden. AIDS. 2012;26(3):345\u201353.","journal-title":"AIDS"},{"issue":"2","key":"1520_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/COH.0b013e32834fcf6b","volume":"7","author":"S Lockman","year":"2012","unstructured":"Lockman S, Sax P. Treatment-for-prevention: clinical considerations. Curr Opin HIV AIDS. 2012;7(2):131\u20139.","journal-title":"Curr Opin HIV AIDS"},{"key":"1520_CR40","doi-asserted-by":"crossref","unstructured":"TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373(9):808\u201322.","DOI":"10.1056\/NEJMoa1507198"},{"key":"1520_CR41","doi-asserted-by":"crossref","unstructured":"INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of antiretroviral therapy in early asymptomatic HIV Infection. N Engl J Med. 2015;373(9):795\u2013807.","DOI":"10.1056\/NEJMoa1506816"},{"key":"1520_CR42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1745-6215-14-230","volume":"14","author":"CC Iwuji","year":"2013","unstructured":"Iwuji CC, Orne-Gliemann J, Tanser F, Boyer S, Lessells RJ, Lert F, et al. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials. 2013;14:230.","journal-title":"Trials"},{"issue":"Suppl 2","key":"1520_CR43","doi-asserted-by":"publisher","first-page":"ii28","DOI":"10.1136\/sti.2008.030346","volume":"84","author":"MC Boily","year":"2008","unstructured":"Boily MC, Desai K, Masse B, Gumel A. Incremental role of male circumcision on a generalised HIV epidemic through its protective effect against other sexually transmitted infections: from efficacy to effectiveness to population-level impact. Sex Transm Infect. 2008;84 Suppl 2:ii28\u201334.","journal-title":"Sex Transm Infect"},{"issue":"5","key":"1520_CR44","doi-asserted-by":"publisher","first-page":"e2212","DOI":"10.1371\/journal.pone.0002212","volume":"3","author":"TB Hallett","year":"2008","unstructured":"Hallett TB, Singh K, Smith JA, White RG, Abu-Raddad LJ, Garnett GP. Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One. 2008;3(5):e2212.","journal-title":"PLoS One"},{"issue":"6","key":"1520_CR45","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/ije\/dyn038","volume":"37","author":"GJ Londish","year":"2008","unstructured":"Londish GJ, Murray JM. Significant reduction in HIV prevalence according to male circumcision intervention in sub-Saharan Africa. Int J Epidemiol. 2008;37(6):1246\u201353.","journal-title":"Int J Epidemiol"},{"issue":"14","key":"1520_CR46","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/QAD.0b013e32830e0137","volume":"22","author":"RG White","year":"2008","unstructured":"White RG, Glynn JR, Orroth KK, Freeman EE, Bakker R, Weiss HA, et al. Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS. 2008;22(14):1841\u201350.","journal-title":"AIDS"},{"issue":"2","key":"1520_CR47","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/sti.2010.043372","volume":"87","author":"TB Hallett","year":"2011","unstructured":"Hallett TB, Alsallaq RA, Baeten JM, Weiss H, Celum C, Gray R, et al. Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sex Transm Infect. 2011;87(2):88\u201393.","journal-title":"Sex Transm Infect"},{"issue":"9","key":"1520_CR48","doi-asserted-by":"publisher","first-page":"e875","DOI":"10.1371\/journal.pone.0000875","volume":"2","author":"UL Abbas","year":"2007","unstructured":"Abbas UL, Anderson RM, Mellors JW. Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings. PLoS One. 2007;2(9):e875.","journal-title":"PLoS One"},{"issue":"11","key":"1520_CR49","doi-asserted-by":"publisher","first-page":"e13646","DOI":"10.1371\/journal.pone.0013646","volume":"5","author":"C Pretorius","year":"2010","unstructured":"Pretorius C, Stover J, Bollinger L, Bacaer N, Williams B. Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa. PLoS One. 2010;5(11):e13646.","journal-title":"PLoS One"},{"issue":"8","key":"1520_CR50","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/sextrans-2012-050891","volume":"89","author":"S Verguet","year":"2013","unstructured":"Verguet S, Stalcup M, Walsh JA. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa? Sex Transm Infect. 2013;89(8):628\u201334.","journal-title":"Sex Transm Infect"},{"issue":"5","key":"1520_CR51","doi-asserted-by":"publisher","first-page":"e2077","DOI":"10.1371\/journal.pone.0002077","volume":"3","author":"DC Vissers","year":"2008","unstructured":"Vissers DC, Voeten HA, Nagelkerke NJ, Habbema JD, de Vlas SJ. The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study. PLoS One. 2008;3(5):e2077.","journal-title":"PLoS One"},{"issue":"11","key":"1520_CR52","doi-asserted-by":"publisher","first-page":"e1001123","DOI":"10.1371\/journal.pmed.1001123","volume":"8","author":"TB Hallett","year":"2011","unstructured":"Hallett TB, Baeten JM, Heffron R, Barnabas R, de Bruyn G, Cremin I, et al. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med. 2011;8(11):e1001123.","journal-title":"PLoS Med"},{"issue":"1","key":"1520_CR53","doi-asserted-by":"publisher","first-page":"e54575","DOI":"10.1371\/journal.pone.0054575","volume":"8","author":"RA Alsallaq","year":"2013","unstructured":"Alsallaq RA, Baeten JM, Celum CL, Hughes JP, Abu-Raddad LJ, Barnabas RV, et al. Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. PLoS One. 2013;8(1):e54575.","journal-title":"PLoS One"},{"issue":"1","key":"1520_CR54","doi-asserted-by":"publisher","first-page":"e84511","DOI":"10.1371\/journal.pone.0084511","volume":"9","author":"A Cori","year":"2014","unstructured":"Cori A, Ayles H, Beyers N, Schaap A, Floyd S, Sabapathy K, et al. HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. PLoS One. 2014;9(1):e84511.","journal-title":"PLoS One"},{"issue":"2","key":"1520_CR55","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/infdis\/jit150","volume":"208","author":"UL Abbas","year":"2013","unstructured":"Abbas UL, Glaubius R, Mubayi A, Hood G, Mellors JW. Antiretroviral therapy and pre-exposure prophylaxis: combined impact on HIV transmission and drug resistance in South Africa. J Infect Dis. 2013;208(2):224\u201334.","journal-title":"J Infect Dis"},{"issue":"1","key":"1520_CR56","first-page":"59","volume":"8","author":"PH Kilmarx","year":"2013","unstructured":"Kilmarx PH, Mutasa-Apollo T. Patching a leaky pipe: the cascade of HIV care. Curr Opin HIV AIDS. 2013;8(1):59\u201364.","journal-title":"Curr Opin HIV AIDS"},{"issue":"3","key":"1520_CR57","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.epidem.2009.08.001","volume":"1","author":"RA Alsallaq","year":"2009","unstructured":"Alsallaq RA, Cash B, Weiss HA, Longini Jr IM, Omer SB, Wawer MJ, et al. Quantitative assessment of the role of male circumcision in HIV epidemiology at the population level. Epidemics. 2009;1(3):139\u201352.","journal-title":"Epidemics"},{"issue":"7","key":"1520_CR58","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/QAD.0b013e3280187544","volume":"21","author":"RH Gray","year":"2007","unstructured":"Gray RH, Li X, Kigozi G, Serwadda D, Nalugoda F, Watya S, et al. The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS. 2007;21(7):845\u201350.","journal-title":"AIDS"},{"issue":"1","key":"1520_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00002030-200501030-00001","volume":"19","author":"S Blower","year":"2005","unstructured":"Blower S, Bodine E, Kahn J, McFarland W. The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. AIDS. 2005;19(1):1\u201314.","journal-title":"AIDS"},{"issue":"18","key":"1520_CR60","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1097\/01.aids.0000433237.63560.20","volume":"27","author":"DA Vijver van de","year":"2013","unstructured":"van de Vijver DA, Nichols BE, Abbas UL, Boucher CA, Cambiano V, Eaton JW, et al. Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models. AIDS. 2013;27(18):2943\u201351.","journal-title":"AIDS"},{"issue":"12","key":"1520_CR61","doi-asserted-by":"publisher","first-page":"e51620","DOI":"10.1371\/journal.pone.0051620","volume":"7","author":"H Tumwebaze","year":"2012","unstructured":"Tumwebaze H, Tumwesigye E, Baeten JM, Kurth AE, Revall J, Murnane PM, et al. Household-based HIV counseling and testing as a platform for referral to HIV care and medical male circumcision in Uganda: a pilot evaluation. PLoS One. 2012;7(12):e51620.","journal-title":"PLoS One"},{"issue":"1","key":"1520_CR62","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/QAI.0b013e31829b567d","volume":"64","author":"H Rooyen van","year":"2013","unstructured":"van Rooyen H, Barnabas RV, Baeten JM, Phakathi Z, Joseph P, Krows M, et al. High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2013;64(1):e1\u20138.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1520-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1520-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1520-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1520-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T08:20:28Z","timestamp":1655626828000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1520-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1520"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1520-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]},"article-number":"189"}}